Depression

Moderate Evidence

Also known as: Depression (Major Depressive Disorder)

Overview

Depression is a common and often serious mental health condition characterized by persistent low mood, reduced interest or pleasure, changes in energy, sleep, appetite, concentration, and overall functioning. In clinical settings, the term often refers to major depressive disorder, but depressive symptoms can also occur in bipolar disorder, seasonal affective disorder, postpartum states, chronic medical illness, and adjustment-related conditions. Depression is distinct from ordinary sadness because it is typically more persistent, more impairing, and often accompanied by cognitive and physical symptoms.

Globally, depression is a leading cause of disability and contributes substantially to reduced quality of life, lost productivity, and increased risk of other health problems. It can affect people across the lifespan, with varied presentations in children, adolescents, adults, and older adults. Depression is also frequently associated with anxiety, chronic pain, cardiovascular disease, sleep disorders, substance use, and metabolic conditions, highlighting its broad whole-body relevance rather than being only a disorder of mood.

From a health ontology perspective, depression is often discussed in relation to supplements and integrative approaches because many individuals explore nutritional, herbal, and mind-body strategies alongside conventional care. Research on nutrients such as omega-3 fatty acids, folate and L-methylfolate, vitamin D, S-adenosylmethionine (SAMe), and botanical agents such as St. Johnโ€™s wort has generated significant interest. However, the evidence is mixed across products, populations, and study designs, and some supplements carry meaningful risks, including drug interactions, variable product quality, and the potential to complicate psychiatric treatment.

Depression is best understood as a multifactorial condition involving biological, psychological, social, and environmental contributors. Genetics, inflammation, neurotransmitter signaling, endocrine function, stress exposure, trauma history, social isolation, sleep disruption, nutritional status, and medical comorbidity may all play roles. Because depression exists on a spectrum of severity and can sometimes involve suicidal thinking or psychosis, evaluation by a qualified healthcare professional is important, especially when symptoms are persistent, worsening, or affecting safety and daily functioning.

Western Medicine Perspective

Western Medicine Perspective

In conventional medicine, depression is understood through a biopsychosocial model. This framework integrates brain and nervous system function, psychological patterns, life stressors, and social determinants of health. Neurobiological research has examined monoamine signaling, neuroplasticity, hypothalamic-pituitary-adrenal axis dysregulation, circadian disruption, inflammation, and network-level changes in brain function. Current psychiatric thinking generally views depression not as a single-cause disorder, but as a heterogeneous syndrome with multiple pathways and subtypes.

Diagnosis is typically based on clinical criteria, symptom duration, impairment, and exclusion of other causes such as thyroid disease, medication effects, substance use, anemia, sleep disorders, or bipolar spectrum illness. Standard conventional approaches may include psychotherapy, lifestyle-focused care, social support interventions, and prescription medications such as antidepressants when appropriate. In more severe or treatment-resistant cases, other modalities may be considered in specialist care settings. Importantly, conventional clinicians also assess for suicide risk, psychotic features, mania, and medical contributors, because these factors can substantially change management.

With respect to supplements, western research has identified some agents with potential adjunctive relevance, but findings remain uneven. Omega-3 fatty acids, especially EPA-dominant formulations, have shown modest benefit in some meta-analyses, particularly as adjuncts. L-methylfolate may have a role in selected individuals, especially where folate metabolism is impaired or deficiency is present. SAMe has been studied for depressive symptoms, though questions remain about long-term safety, standardization, and risk of mood switching in vulnerable individuals. St. Johnโ€™s wort has evidence for mild to moderate depression in some trials, but conventional medicine emphasizes its major interaction potential with antidepressants, oral contraceptives, anticoagulants, transplant medications, and many other drugs through cytochrome P450 effects. Product variability is another concern.

Overall, the western view is that supplements may be relevant in certain contexts, but they are not regarded as universally appropriate or equivalent to a full diagnostic and treatment evaluation. Research supports a cautious, individualized, evidence-informed approach, particularly because depression may coexist with conditions requiring urgent medical or psychiatric attention.

Eastern & Traditional Perspective

Eastern / Traditional Medicine Perspective

In Traditional Chinese Medicine (TCM), depressive states are not usually framed as a single disease entity identical to modern psychiatric diagnosis. Instead, symptoms may be understood through patterns such as Liver qi stagnation, Heart and Spleen deficiency, phlegm misting the mind, or disharmony affecting the shen (spirit/mind). Emotional distress is often seen as closely tied to the movement of qi, blood, and organ-system balance. Traditional approaches may include herbal formulas, acupuncture, dietary patterning, breathing practices, and regulation of sleep and daily rhythms, with treatment individualized to the personโ€™s pattern rather than to the label of depression alone.

In Ayurveda, depression-like presentations may be interpreted through disturbances in gunas and doshas, particularly states involving excess tamas or imbalances of vata and kapha, depending on the symptom pattern. Emotional heaviness, low motivation, mental fog, and withdrawal may be understood differently from anxiety-dominant agitation or depletion. Ayurvedic care has traditionally included herbal preparations, meditation, yoga, daily routine regulation, digestive support, and attention to sensory and spiritual influences. Herbs such as ashwagandha, brahmi (Bacopa monnieri), and related rasayana plants are often discussed in integrative contexts, though modern evidence for depression specifically remains limited or mixed.

In naturopathic and broader traditional/integrative frameworks, depression is often explored through a whole-person lens that includes stress physiology, sleep, inflammation, nutrient status, gut health, trauma exposure, social connection, and constitutional factors. These systems frequently emphasize foundations such as rhythm, nourishment, movement, and mind-body regulation alongside selected botanicals or nutrients. Research into acupuncture and certain herbal or nutritional strategies suggests possible benefit for some individuals, but study quality is variable and blinding can be difficult in traditional interventions.

Across eastern and traditional systems, a recurring theme is that emotional suffering reflects broader imbalance rather than isolated brain chemistry alone. At the same time, responsible integrative practice generally recognizes that severe depression, suicidality, psychosis, or bipolar features require prompt assessment by licensed medical and mental health professionals. Traditional approaches are often positioned as complementary frameworks rather than replacements for urgent or evidence-based psychiatric care.

Related Topics

Chronic Pain

Chronic Pain โ€” a condition in the health ontology.

Anxiety

Anxiety โ€” a condition in the health ontology.

Vitamin D3

Vitamin D3 โ€” a supplement in the health ontology.

Epilepsy

Epilepsy โ€” a condition in the health ontology.

Hypothyroidism

Hypothyroidism โ€” a condition in the health ontology.

Migraine

Migraine โ€” a condition in the health ontology.

How They Relate

Condition / Condition

Chronic Pain & Depression (Major Depressive Disorder)

Chronic pain and depression frequently travel together, creating a bidirectional cycle where each condition can precipitate, amplify, and maintain the other. Epidemiologic studies show substantiall...

Condition / Condition

Depression & Anxiety

Depression and anxiety frequently travel together, share many risk factors, and respond to overlapping treatments. Epidemiologic studies show high bidirectional comorbidity: a large proportion of p...

Supplement / Condition

Depression & Vitamin D

Depression is a common mental health condition with biological, psychological, and social contributors. Vitamin D, a hormone-like nutrient produced in skin with sunlight exposure and obtained from ...

Condition / Condition

Epilepsy & Depression

Epilepsy and depression have a strong, bidirectional relationship that affects diagnosis, treatment choices, quality of life, and safety. Depression is among the most common comorbidities in people...

Condition / Condition

Hypothyroidism & Depression

Hypothyroidism and depression frequently overlap clinically and biologically. Thyroid hormones influence brain development, neurotransmission, and energy metabolism; when thyroid levels are low (ov...

Condition / Condition

Migraines & Depression

Migraines and depression frequently co-occur and influence one another in clinically meaningful ways. Population studies consistently show a bidirectional association: people with migraine have abo...

Condition / Condition

Parkinson's Disease & Depression

Parkinsonโ€™s disease (PD) and depression frequently co-occur and influence each otherโ€™s course, symptoms, and treatment choices. Depression is among the most common non-motor symptoms of PD, affecti...

Evidence & Sources

Moderate Evidence

Promising research with growing clinical support from multiple studies

  1. World Health Organization (WHO)
  2. National Institute of Mental Health (NIMH)
  3. American Psychiatric Association Practice Guideline for the Treatment of Patients With Major Depressive Disorder
  4. National Center for Complementary and Integrative Health (NCCIH)
  5. Cochrane Database of Systematic Reviews
  6. JAMA Psychiatry
  7. The Lancet Psychiatry
  8. American Journal of Psychiatry
  9. BMJ
  10. Molecular Psychiatry

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.